Virodhamine (O-arachidonoyl ethanolamine) is an endocannabinoid and a nonclassic eicosanoid, derived from arachidonic acid. O-Arachidonoyl ethanolamine is arachidonic acid and ethanolamine joined by an ester linkage, the opposite of the amide linkage found in anandamide. Based on this opposite orientation, the molecule was named virodhamine from the Sanskrit word virodha, which means opposition. It acts as an antagonist of the CB1 receptor and agonist of the CB2 receptor. Concentrations of virodhamine in the human hippocampus are similar to anandamide, but they were 2- to 9-fold higher in peripheral tissues that express CB2. Virodhamine lowers body temperature in mice, demonstrating cannabinoid activity in vivo.[1]
See also
References
|
Cannabinoids |
|
| Plant cannabinoids |
|
|
| Cannabinoid metabolites |
|
|
| Endogenous cannabinoids |
|
|
Synthetic cannabinoid
receptor agonists |
|
Classical cannabinoids
(Dibenzopyrans)
|
|
|
|
Nonclassical cannabinoids
|
|
|
|
Aminoalkylindoles
|
|
|
|
Aminoalkylpyrroles
|
|
|
|
Eicosanoids
|
AM-883 • Arachidonyl-2'-chloroethylamide • Arachidonylcyclopropylamide • Methanandamide • O-585 • O-689 • O-1812 • O-1860 • O-1861
|
|
|
Others
|
|
|
|
Endocannabinoid
activity enhancers |
|
|
Cannabinoid receptor
antagonists and
inverse agonists |
|
|
|
Autacoids, unsaturated fatty acids: Eicosanoids |
|
| Precursor |
|
|
| Prostanoids |
|
|
| Leukotrienes (LT) |
|
|
| Nonclassic |
|
|
| By function |
bronchoconstriction ( PGF2α, TXA2, LTC4, LTD4, LTE4)
vasoconstriction (PGF2α, TXA2, TXB2) · vasodilation (PGE2, PGI2, LTC4, LTD4, LTE4)
platelets: induce (TXA2) inhibit (PGD2, PGI2) · leukocytes: induce (TXA2, LTB4) inhibit (PGD2, PGE2)
labor stimulation: ( PGE2 (Dinoprostone), PGF2α (Dinoprost))
|
|
|
|
|
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)